WellTheory Raises $7.2M in Seed Funding
Summary
WellTheory, a San Francisco, CA-based provider of a solution to support individuals with autoimmune disorders, raised $7.2m in seed funding. The round was led by Accel with participation from Lux Capital, Box Group, Scribble Ventures, Rock Health, and the CEOs of Maven, Everlane, Pillpack. The company intends to use the funds to expand operations and its development efforts. The company combines food as medicine, community care, and personalized insights from health data to build a membership experience that supports women no matter where they are in their autoimmune journey. The company’s team has deep startup experience, including at Oscar Health, Dropbox, Everlane, and Bill.com.
Funding
Review available funding amount, funding date, investors, and linked company information related to WellTheory Raises $7.2M in Seed Funding in the interactive ISVWorld profile.